Product image of Diazepam Slovakofarma (Diazepam) supplied by GNH India

Diazepam Slovakofarma

Active Ingredient:
Diazepam
Origin:
EU

Diazepam Slovakofarma (Diazepam)

Diazepam Slovakofarma is a prescription medication that contains the active ingredient diazepam, a benzodiazepine class drug, supplied in an oral dosage form and marketed within the European Union. It is classified as a Schedule IV controlled substance and is used under medical supervision for several central nervous system indications. It works by enhancing the activity of the neurotransmitter GABA, leading to reduced neuronal excitability and is available in tablet strengths.

Manufacturer / TM Owner

Zentiva, K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Diazepam Slovakofarma is prescribed for several conditions that involve excessive central nervous system activity.

  • Management of anxiety disorders and related symptoms.
  • Short‑term treatment of insomnia associated with anxiety.
  • Relief of muscle spasms and spasticity.
  • Adjunct therapy for certain seizure disorders.
  • Support during alcohol‑withdrawal syndrome.

Side Effects

Side effects of diazepam may vary in frequency and severity, and they are reported in clinical use of Diazepam Slovakofarma.

Common

  • Drowsiness or fatigue
  • Light‑headedness or dizziness
  • Muscle weakness
  • Impaired coordination

Serious

  • Respiratory depression, especially with high doses or other depressants
  • Severe allergic reactions such as rash, swelling, or anaphylaxis
  • Paradoxical reactions including increased anxiety, agitation, or aggression

Precautions & Warnings

Before initiating therapy with Diazepam Slovakofarma, clinicians consider several safety factors to minimize risks.

  • Assess for a history of substance misuse or dependence.
  • Use the lowest effective dose for the shortest duration possible.
  • Avoid use during pregnancy unless clearly indicated; it is classified as Category D.
  • Monitor patients with hepatic or renal impairment closely.
  • Caution in elderly patients due to increased sensitivity to sedation.
  • Do not discontinue abruptly; tapering is recommended to prevent withdrawal symptoms.

Avoid Interactions

Diazepam can interact with other medicines, affecting its sedative effect or metabolism, so careful review of concomitant drugs is essential.

Avoid

  • Concurrent use with other central nervous system depressants such as opioids, barbiturates, or alcohol.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) that can markedly increase diazepam levels.

Use with caution

  • CYP2C19 poor metabolizers or drugs that affect CYP2C19 activity.
  • Antidepressants, antipsychotics, or antihistamines that may enhance sedation.
  • Certain anticonvulsants (e.g., carbamazepine, phenytoin) that can lower diazepam concentrations.

Frequently Asked Questions

Diazepam Slovakofarma is classified as an anxiolytic benzodiazepine, used to reduce anxiety and related symptoms.

No. Diazepam Slovakofarma is a prescription‑only medication and is regulated as a Schedule IV controlled substance.

Diazepam Slovakofarma is assigned to pregnancy Category D, indicating potential risk to the fetus; it should be used only if clearly needed and prescribed by a healthcare professional.

Diazepam acts as a positive allosteric modulator of GABA‑A receptors, enhancing the inhibitory effect of the neurotransmitter GABA in the central nervous system.

Common indications include anxiety disorders, short‑term insomnia, muscle spasms, certain seizure disorders, and management of alcohol‑withdrawal symptoms.

The most common side effects are drowsiness, dizziness, muscle weakness, and impaired coordination.

Serious reactions can include respiratory depression, severe allergic responses, and paradoxical reactions such as increased agitation or anxiety.

Abrupt discontinuation is not recommended; a gradual tapering schedule should be followed under medical supervision to avoid withdrawal symptoms.

Concurrent use with other central nervous system depressants (e.g., opioids, barbiturates, alcohol) and strong CYP3A4 inhibitors should be avoided.

Elderly patients may be more sensitive to sedation and should start at lower doses with careful monitoring.

Yes, hepatic or renal impairment can alter drug clearance, so dose adjustments and close monitoring are advised.

Regular assessment of sedation level, respiratory function, signs of dependence, and liver/kidney function tests are commonly recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.